Evidence map›Paper›PMID 18697751›Full record

ArticleThe Journal of biological chemistry2008

Despite increased ATF4 binding at the C/EBP-ATF composite site following activation of the unfolded protein response, system A transporter 2 (SNAT2) transcription activity is repressed in HepG2 cells.

Altin Gjymishka, Stela S Palii, Jixiu Shan, Michael S Kilberg

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Melatonin Attenuates HInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  13. The SLC38 family of sodium-amino acid co-transporters.Pflugers Archiv : European journal of physiology · 2014
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Altin GjymishkaDepartment of Biochemistry and Molecular Biology, Genetics Institute, Shands Cancer Center and Center for Nutritional Sciences, University of Florida College of Medicine, Gainesville, Florida 32610.
Stela S PaliiDepartment of Biochemistry and Molecular Biology, Genetics Institute, Shands Cancer Center and Center for Nutritional Sciences, University of Florida College of Medicine, Gainesville, Florida 32610.
Jixiu ShanDepartment of Biochemistry and Molecular Biology, Genetics Institute, Shands Cancer Center and Center for Nutritional Sciences, University of Florida College of Medicine, Gainesville, Florida 32610.
Michael S KilbergDepartment of Biochemistry and Molecular Biology, Genetics Institute, Shands Cancer Center and Center for Nutritional Sciences, University of Florida College of Medicine, Gainesville, Florida 32610. Electronic address: mkilberg@ufl.edu.

Funding

NUTRITIONAL CONTROL OF ASPARAGINE SYNTHETASER01DK052064 · NIDDK · UNIVERSITY OF FLORIDA · PI KILBERG, MICHAEL S. · 1997 to 2010
$3.4M
Nutritional Regulation of Ribosomal Protein ExpressionR01DK059315 · NIDDK · UNIVERSITY OF FLORIDA · PI KILBERG, MICHAEL S. · 2001 to 2005
$1.2M
NIDDK NIH HHS DK-52064NIDDK NIH HHS DK-59315NIDDK NIH HHS R01 DK052064NIDDK NIH HHS R01 DK059315
6 · The paper itself

Abstract

The activated amino acid response (AAR) and unfolded protein response (UPR) stress signaling pathways converge at the phosphorylation of translation initiation factor eIF2alpha. This eIF2alpha modification suppresses global protein synthesis but enhances translation of selected mRNAs such as that for activating transcription factor 4 (ATF4). An ATF4 target gene, SNAT2 (system A sodium-dependent neutral amino acid transporter 2), contains a C/EBP-ATF site that binds ATF4 and triggers increased transcription during the AAR. However, the present studies show that despite increased ATF4 binding to the SNAT2 gene during UPR activation in HepG2 human hepatoma cells, transcription activity was not enhanced. Hyperacetylation of histone H3 and recruitment of the general transcription factors at the HepG2 SNAT2 promoter occurred in response to the AAR but not the UPR. In contrast, the UPR did enhance transcription from a plasmid-based reporter gene driven by a SNAT2 genomic fragment containing the C/EBP-ATF site. Simultaneous activation of the AAR and the UPR pathways revealed that the UPR actually suppressed the increased SNAT2 transcription by the AAR pathway, demonstrating that the UPR pathway generates a repressive signal that acts downstream of ATF4 binding.

Indexed as

Protein FoldingAcetylationActivating Transcription Factor 4Amino Acid Transport System AAnimalsCCAAT-Enhancer-Binding ProteinsCell Line, TumorEukaryotic Initiation Factor-2HistonesHumansMiceProtein BiosynthesisResponse ElementsRNA, MessengerSignal TransductionTranscription, GeneticActivating Transcription Factor 4Amino Acid Transport System AATF4 protein, humanAtf4 protein, mouseCCAAT-Enhancer-Binding ProteinsEukaryotic Initiation Factor-2HistonesRNA, MessengerSLC38A2 protein, human

Identifiers

PMID18697751
PMCPMC2562058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.